Workflow
XPENG Launches Global OTA 5.8.0 Update: Delivering Refined Experiences for Diverse User Demands
Globenewswire· 2025-08-25 03:31
Core Insights - XPENG Motors announced the global OTA upgrade of XOS 5.8.0, enhancing user experience through intelligent driving and smart cabin technologies [1][3] - The upgrade is part of XPENG's commitment to user-centric innovation, following previous successful OTA releases in 2025 [2][3] Intelligent Driving Features - The XOS 5.8.0 upgrade introduces the Human-Machine Co-Driving feature, making XPENG the first automaker in Europe to offer this standard [4] - Lane Centering Control (LCC) has been improved to maintain control during driver steering, enhancing performance in complex driving scenarios [5] - Adaptive Cruise Control (ACC) has also been significantly enhanced for better cornering speeds and smoother deceleration [5] New User-Centric Features - A new Pet Mode has been introduced to ensure safety and comfort for pets left unattended in vehicles, with automatic window closure and climate control [6][7] - The AUTO Climate Control Mode allows for external air circulation, preventing overheating or excessive cold, with real-time alerts sent to owners [7] Entertainment and Personalization - The upgrade includes a new hands-free in-car karaoke feature, KaraFun, available for download from the in-car App Store [9] - XCOMBO has been upgraded to support 21 languages and over 700 capabilities, allowing users to create personalized scenarios for their driving experience [12] Commitment to User Experience - XPENG emphasizes a user-centric philosophy, tailoring intelligent technology experiences to customer needs, including a smarter charging experience and enhanced safety features [11][14] - The air conditioning minimum temperature has been adjusted to 16°C in response to user feedback from tropical climates [11]
Willis accelerates growth in Japan with talent hires and expansion into specialty lines
Globenewswire· 2025-08-25 02:00
Company Expansion - Willis, a WTW business, announced a significant expansion of its Japanese Corporate Risk & Broking team, enhancing its ability to meet rising demand in Japan through deepened industry expertise and analytics [1] - The company has hired 22 new professionals across various business areas, significantly expanding its client-facing teams [2][3] Market Insights - The Japanese general insurance market is projected to grow from JPY 11.7 trillion (US$ 81.1 billion) in 2024 to JPY 12.7 trillion (US$ 93.9 billion) by 2028, at a compound annual growth rate of 2.2% [2] - Growth drivers include commercial lines, digital transformation, risk advisory services, and increased demand for protection against climate change, natural catastrophes, cyber threats, and supply chain disruptions [2] Specialty Lines and Talent Acquisition - Recent hires include professionals in Risk & Analytics, Facultative Reinsurance, Marine specialty line, Business Development, Large Account, and Claims, reflecting the company's commitment to supporting clients with large and complex risks [3] - The new talent includes individuals from leading companies such as Marsh, Aon, Tokio Marine, Mitsui Sumitomo, Marubeni, and Moody's RMS [3]
HUTCHMED Announces Appointment of Acting Chief Executive Officer
Globenewswire· 2025-08-25 00:20
Core Viewpoint - HUTCHMED announces the temporary leave of its CEO Dr. Weiguo Su due to health reasons, with CFO Johnny Cheng appointed as Acting CEO to ensure continuity in operations and strategy execution [1][2]. Company Leadership Changes - Dr. Weiguo Su, the Executive Director and CEO, is taking a leave of absence for health reasons, emphasizing the need to focus on his recovery [1][2]. - Johnny Cheng, currently the Executive Director and CFO, has been appointed as Acting CEO, effective immediately, while continuing his role as CFO [1][2]. Board Support and Confidence - The Board of Directors expresses full support for Dr. Su and confidence in Mr. Cheng's capabilities to manage the company during this interim period [2]. - The Board reassures stakeholders that all research, development, and commercial initiatives will remain on track despite the leadership change [2]. Company Overview - HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases [3]. - The company has successfully marketed its first three medicines in China, with the first also approved in global markets including the US, Europe, and Japan [3].
Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025
Globenewswire· 2025-08-23 11:00
Group 1 - IDEX Biometrics ASA conducted a private placement of 9,090,909 shares at NOK 3.30 per share, divided into two tranches [1] - In tranche 2, a total of 4,813,857 shares were included, which also accounted for underwriting shares [1] - Pinchcliffe AS and CEO Anders Storbråten subscribed to 469,255 and 703,883 shares respectively, resulting in Storbråten and close relations holding 7,195,898 shares, or 13.81% of total outstanding shares after tranche 2 [2] Group 2 - K-konsult AS, related to chair Morten Opstad, subscribed to 153,343 shares, while Opstad subscribed to 50,000 shares at the same price of NOK 3.30 per share [3] - IDEX Biometrics is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company collaborates with leading card manufacturers and technology firms to market its biometric solutions, which are based on proprietary sensor technologies and integrated circuit designs [3] Group 3 - The notice regarding the private placement was issued by COO Kjell-Arne Besseberg on 23 August 2025, in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act [4]
Faircourt Asset Management Inc. Announces August Distribution
Globenewswire· 2025-08-23 00:00
Group 1 - Faircourt Asset Management Inc. announced a monthly distribution for the Faircourt Gold Income Corp. fund, with a distribution amount of $0.024 per share [1][2] - The ex-dividend date is set for August 29, 2025, and the payable date for the distribution is September 15, 2025 [2] - Faircourt Asset Management Inc. serves as the Investment Advisor for Faircourt Gold Income Corp. [2] Group 2 - The press release specifies that it is not for distribution in the United States or over U.S. wire services [2] - Investors may incur brokerage fees when buying or selling shares of the fund on the CBOE Canada Exchange or other Canadian trading systems [2] - The value of investment funds can fluctuate, and past performance is not indicative of future results [3]
Mustang Energy Corp. Completes Sampling Program at Surprise Creek Project, Saskatchewan and Provides Update on the Acquisition of the Ford Lake Project
Globenewswire· 2025-08-22 22:57
Core Insights - Mustang Energy Corp. has completed the first phase of field exploration activities on the Surprise Creek Uranium-Copper Project, acquiring an 80% interest through an option agreement with Thunderbird Resources Ltd. [1][2] Exploration Activities - The field program included surface prospecting and detailed rock sampling to refine target areas and outline mineralization [2] - Surface samples were collected from nine locations where previous uranium and copper mineralization was observed, with structural data collected from the Surprise Creek Fault area [2] Project Location and Historical Context - The Surprise Creek Project is located 25 km northwest of the Beaverlodge Uranium District, known for historical uranium mines [3] - A high-resolution airborne survey completed in September 2024 identified multiple new uranium targets in the area [4] Mineralization Findings - A strong uranium radiometric anomaly was identified at the Surprise Creek Fault drill target, with historical drilling returning results of up to 2.1m of 4.37% U3O8 from 57m [5] - Surface sampling returned assays up to 7.98% U3O8, with mineralization extending over a strike length of up to 500 m [5] Copper Prospects - The Project also contains historical copper prospects, with drilling results including 9.1m at 2.07% Cu and 27.3g/t Ag from surface at Bob Lake [7] - Rock chip sampling returned assays of up to 61.7% Cu, 27.6% Cu, and 9% Cu from historical copper occurrences [7] Regulatory Approvals - A work permit application for exploration, including drilling at the Surprise Creek Fault prospect, has been approved by the Saskatchewan Government [8] Company Overview - Mustang Energy is focused on discovering and developing high-potential uranium and critical mineral assets, holding a portfolio of 147,153 hectares in Saskatchewan's Athabasca Basin [17]
METALSOURCE ANNOUNCES LOAN AGREEMENT
Globenewswire· 2025-08-22 22:42
VANCOUVER, BRITISH COLUMBIA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- METALSOURCE MINING INC. (the “Company” or "Metalsource") (CSE: “MSM”) announces that it has entered into a loan agreement with an arm’s-length third party (the “Lender”) pursuant to which the Company shall borrow from the Lender $50,000 at a 5% per annum interest rate. In addition, the Company shall issue the Lender 25,000 warrants, exercisable at $0.20 per share for a term of 2 years. About Metalsource Mining The Company is engaged in acquisiti ...
Elite Express Holding Inc. Announces Closing of $15.2 Million Initial Public Offering
Globenewswire· 2025-08-22 22:07
Company Overview - Elite Express Holding Inc. (ETS) is a Delaware holding company that operates through its wholly owned subsidiary, JAR Transportation Inc., based in California [5] - ETS specializes in last-mile delivery services, focusing on transporting packages from distribution centers to end customers within defined service areas [5] - The company utilizes logistics software to enhance operational efficiency, route planning, driver oversight, and regulatory compliance [5] Initial Public Offering (IPO) Details - ETS announced the closing of its initial public offering of 3,800,000 shares of Class A common stock at an offering price of $4.00, resulting in gross proceeds of approximately $15.2 million before deductions [1] - The shares began trading on The Nasdaq Capital Market under the ticker symbol "ETS" on August 21, 2025 [2] - Underwriters for the offering include Dominari Securities LLC as the representative and Revere Securities as co-underwriter, with Pacific Century Securities, LLC acting as the advisor to ETS [2] Regulatory Filings - A registration statement on Form S-1 was filed with the U.S. Securities and Exchange Commission (SEC) and became effective on August 20, 2025 [3] - The offering is conducted solely by means of a prospectus that is part of the effective registration statement, with a final prospectus available on the SEC's website [3]
Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for Ps. 8.5 Billion
Globenewswire· 2025-08-22 21:35
GUADALAJARA, Mexico, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC; BMV: GAP) (“the Company” or “GAP”) announces that today completed successfully the issuance of 85 million long-term bond certificates in Mexico (Certificados Bursátiles) for a total amount of Ps. 8.5 billion (EIGHT POINT FIVE BILLION PESOS 00/100 M.N.). The issuance was carried through two tranches and reached the total authorized amount. The order book reached an oversubscription of 1.98 time ...
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
Globenewswire· 2025-08-22 21:01
Core Insights - Aptose Biosciences Inc. is advancing its clinical-stage precision oncology drug, tuspetinib, for treating newly diagnosed acute myeloid leukemia (AML) [1][4] - The company has received an additional US$1.5 million from Hanmi Pharmaceutical as part of an US$8.5 million loan facility to support the development of tuspetinib [3] - Shareholders have appointed Ernst & Young LLP as the new independent auditor, which is expected to enhance the company's transparency and growth in the life sciences sector [2] Financial Updates - The total amount received by Aptose under the loan agreement with Hanmi to date is US$7.1 million, indicating significant financial backing for ongoing clinical development [3] - The additional advance of US$1.5 million is part of a structured financial strategy to ensure continued progress in drug development [3] Corporate Governance - The appointment of Ernst & Young LLP as the independent auditor reflects the company's commitment to maintaining high standards of financial oversight and transparency [2] - The decision was made during a reconvened annual and special meeting of shareholders, highlighting active shareholder engagement in corporate governance [1][2]